An Open-label Trial With TMC125 in Patients Who Have Virologically Failed in a DUET Trial (TMC125-C206 or TMC125-C216).
Clinical trial NCT00359021 · COMPLETED
Trial details
- NCT number
- NCT00359021
- Sponsor
- Tibotec Pharmaceuticals, Ireland
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-06-01
- Primary completion
- 2012-01-01
- Enrollment
- 503
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.